Skip to main content

What do you think about the HUS.fi website?

Answer a short survey and tell us what you think about our website.

The survey only takes a few minutes. The survey can be completed in Finnish, Swedish or English. Select the language from the upper right corner of the survey.

Thank you for your time!

Click here to answer the survey
 

Article Published on 18.11.2026 11.52

The biobank acts as a bridge between research and healthcare

Keywords:

If a person who has given their biobank consent gives their permission, the research data produced from their sample can be used to promote their health. Biobank research results have been used, for example, to develop an individual preventive care pathway and help target treatments.

""

Like other medical research, research carried out on biobank samples is often slow. The results benefit future generations, and the sample provider is not expected to benefit from donating. However, sometimes the tests may reveal information that is significant to the health of the person who provided the sample, which can then be used in their treatment.

In connection with biobank consent, donors are always asked whether they want to know if something significant to their health is found in the sample. 99 per cent of those who give consent also tick this box. So, what can be found in the samples?

"The findings of biobank samples depend on the research carried out with them. If genetic information has been produced from the sample, it can be used to determine disease risks or to help choose the right treatment," says Scientific Director of the Helsinki Biobank, Professor Olli Carpén.

Finnish hospital biobanks are integrated into health care services, so they are in an excellent position to act as a bridge between research and healthcare.

In various research projects, the Helsinki Biobank and HUS physicians have developed and tested how to use data produced from biobank samples in supporting treatment. In this article, we give three examples of how findings from biobank research have been applied in healthcare.

Disease prevention based on genetic data and a preventive care pathway

The GenomiTerveys project, coordinated by the Helsinki Biobank, investigated whether genetic information produced from biobank samples can be utilized in healthcare. Finland's hospital biobanks built a uniform process, covering the entire country, for returning genetic information on the risk of disease to sample donors and for forwarding it to health care.  

The process was piloted using genomic data returned from the FinnGen research project, and studied variants of the BRCA1, BRCA2 and PALB2 genes that predispose to, for example, breast cancer.

"We contacted sample donors who had indicated their willingness to receive health-relevant information in their biobank consent, and we offered them the opportunity to obtain information on the genetic cancer risk," says the Project Manager, Clinical Laboratory Geneticist Minja Pehrsson.

If the sample donor wanted to receive information, the result was returned from the biobank. Sample donors who were diagnosed with a gene variant that increased their cancer risk were referred to health care for confirmation of the result and genetic counselling. Once the result was confirmed, the persons were referred to intensified monitoring or preventive measures.

"Information about the increased risk of cancer helps in cancer prevention and the planning of individual follow-up, and at the same time, relatives can also seek out testing. Although some genetic variants increase susceptibility to certain cancers, early detection of cancer clearly improves the chances of cure.," Carpén says.

Molecular profiling of cancer helps to target treatment

In the extensive and ongoing iCAN research project, molecular profiling data on cancerous tumors has been produced from biobank samples. This data provides information on the individual characteristics of the tumor. In addition, the project has piloted the return of information to the patient and the treating physician, who could use the information to target treatment.

The study examined, for example, genetic changes occurring in cancer cells and which drugs effectively killed the cancer cells. Because the information must be quickly made available to healthcare services for it to be used in treatment decisions, a separate process was needed. 

Most of the study patients have been children with cancer, and so far, the research data of 14 patients has been submitted to the treating physician allowing to treat the patients more effectively.

Confirming diagnoses of rare diseases

In addition to cancer, biobank research has been used to produce information on rare diseases for health care. Biobank samples, together with linked health data, can help identify rare diseases.

In the RARE3K research project, a joint project of HUS Rare Diseases Center, Helsinki Biobank, and Blueprint Genetics Oy, health data of the biobank sample donors were used to search for persons who could have one of the four hereditary rare diseases selected for the study, such as retinal degeneration or hereditary growth disorder. The diseases selected for the study were ones for which a new medicinal treatment is being developed or has recently been introduced.

If a person's health records indicated one of these diseases, DNA sequencing was performed on their biobank sample to look for a gene variant that predisposes to the disease in question. Systematic analysis of health data and genetic testing of biobank samples helped to identify previously undiagnosed individuals. After this, the doctors involved in the study contacted the identified persons, and they were referred for treatment at HUS. 

The study produced valuable information on how biobank data can be used to speed up the identification of rare diseases.

Feedback

Did you find what you were looking for?

Thank you for your feedback!

Thank you for your feedback!

Write your feedback on the website here.

Do not enter your personal information here. Please note that we do not respond to feedback sent via this form. Please visit our feedback site to give feedback on matters other than our website.

Write your feedback on the website here.

Do not enter your personal information here. Please note that we do not respond to feedback sent via this form. Please visit our feedback site to give feedback on matters other than our website.